Use of dapagliflozin in patients with advanced diabetic kidney disease

Sodium-glucose cotransporter-2 (SGLT2) inhibitors are effective for overweight diabetic patients through the induction of glucosuria. However, SGLT2 inhibitors are not recommended for patients with advanced chronic kidney disease (CKD) because they may aggravate renal function and thus become less e...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Kidney Res Clin Pract
Main Authors: Park, Hyun Sun, Jung, Youn Joo, Lee, Dong-Young, Moon, Kyoung Hyoub, Kim, Beom, Kim, Hae Won
Format: Artigo
Sprog:Inglês
Udgivet: Korean Society of Nephrology 2018
Fag:
Case Report
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6147181/
https://ncbi.nlm.nih.gov/pubmed/30254854
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.23876/j.krcp.2018.37.3.292
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker